Literature DB >> 15073162

Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over an 11 year period.

Pierre-Yves Donnio1, Laure Preney, Anne-Lise Gautier-Lerestif, Jean-Loup Avril, Nathalie Lafforgue.   

Abstract

BACKGROUND: In this study, we investigated the relationship between changes in antibiotic resistance and distribution of staphylococcal cassette chromosome (SCC) types amongst methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing the most frequently encountered profiles of antibiotic resistance over an 11 year period in the University Hospital of Rennes, France.
METHODS: Antibiotic susceptibilities were determined by agar diffusion. SCC typing was performed using PCR. PFGE demonstrated that isolates were phylogenetically related.
RESULTS: Fourteen profiles of antibiotic resistance were defined among MRSA isolates. For each resistance profile, only one SCC type was associated: four patterns corresponded to SCC type I or IA, nine to SCC type IV or IVA, and none to types II and III. One was not typed. PFGE indicated that isolates with SCC type I or IA belong to a single genetic lineage, which also includes most of the epidemic isolates, which carry SCC type IVA. In contrast to type I or IA, isolates with SCC type IV or IVA were found to be associated with several different PFGE clusters, although not all of these represent epidemic isolates.
CONCLUSIONS: During the course of the study, the spectrum of antibiotic resistance in MRSA isolates decreased. This occurred due to the emergence of strains with SCC type IV or IVA, which are susceptible to more antibiotics than type I or IA strains. The greater prevalence of such isolates could not be linked conclusively to the presence of SCC type IV or IVA, or to one particular PFGE cluster.

Entities:  

Mesh:

Year:  2004        PMID: 15073162     DOI: 10.1093/jac/dkh185

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Dissemination of multisusceptible methicillin-resistant Staphylococcus aureus in Singapore.

Authors:  Li-Yang Hsu; Tse-Hsien Koh; Kamaljit Singh; Mei-Ling Kang; Asok Kurup; Ban-Hock Tan
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Prevalence and evolution of methicillin-resistant Staphylococcus aureus in Spanish hospitals between 1996 and 2002.

Authors:  A Vindel; P Trincado; E Gómez; R Cabrera; T Boquete; C Solá; S Valdezate; J A Saez-Nieto
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period.

Authors:  D S Blanc; C Petignat; A Wenger; G Kuhn; Y Vallet; D Fracheboud; S Trachsel; M Reymond; N Troillet; H H Siegrist; S Oeuvray; M Bes; J Etienne; J Bille; P Francioli; G Zanetti
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

4.  Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital.

Authors:  M L Amorim; N A Faria; D C Oliveira; C Vasconcelos; J C Cabeda; A C Mendes; E Calado; A P Castro; M H Ramos; J M Amorim; H de Lencastre
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

5.  Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital.

Authors:  A M Strandén; R Frei; H Adler; U Flückiger; A F Widmer
Journal:  Infection       Date:  2008-10-30       Impact factor: 3.553

6.  Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.

Authors:  C Camus; V Sebille; A Legras; B Garo; A Renault; P Le Corre; P-Y Donnio; A Gacouin; D Perrotin; Y Le Tulzo; E Bellissant
Journal:  Infection       Date:  2014-01-25       Impact factor: 3.553

7.  Characterization of methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus spp. isolated from US West Coast public marine beaches.

Authors:  Olusegun O Soge; John S Meschke; David B No; Marilyn C Roberts
Journal:  J Antimicrob Chemother       Date:  2009-10-16       Impact factor: 5.790

8.  Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain.

Authors:  Virginie Mick; M Angeles Domínguez; Fe Tubau; Josefina Liñares; Miquel Pujol; Rogelio Martín
Journal:  BMC Microbiol       Date:  2010-03-04       Impact factor: 3.605

9.  Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections.

Authors:  Cynthia L Maree; Robert S Daum; Susan Boyle-Vavra; Kelli Matayoshi; Loren G Miller
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

10.  Methicillin-resistant Staphylococcus aureus USA300 clone in long-term care facility.

Authors:  Pierre Tattevin; Binh An Diep; Michael Jula; Françoise Perdreau-Remington
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.